-

SHAREHOLDER ALERT: Kaskela Law LLC Announces Class Action Lawsuit Against Globe Life Inc. (GL) and Encourages Long-Term GL Investors to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Globe Life Inc. (NYSE: GL), formerly known as Torchmark Corp., on behalf of investors who purchased shares of the Company’s stock between May 8, 2019 and April 10, 2024.

According to the complaint, during that time period Globe Life issued a series of materially false and misleading statements to investors, in violation of the federal securities laws.

As further detailed in the complaint, on April 11, 2024, investment research firm Fuzzy Panda “reported that Globe Life and its subsidiaries had engaged in widespread insurance fraud by adding policies to existing users’ account without their consent, as well as underwriting policies for dead and fictitious people. The article also revealed that Globe Life also maintained a hostile workplace where sexual harassment, drug use, and sexual assault went unchecked.” Following this report, the price of Globe Life common stock declined by $55.76 per share, or 53%, from a closing price of $104.93 per share on April 10, 2024, to a closing price of $49.17 per share on April 11, 2024.

Current Globe Life shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 or (888) 715 – 1740, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/globe-life/ , for additional information about this action and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

Industry:

Kaskela Law LLC

NYSE:GL
Release Versions
English

Contacts

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

More News From Kaskela Law LLC

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Select Medical Holdings Shareholder Buyout and Encourages Investors to Contact the Firm – SEM

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) on behalf of the company’s shareholders to determine whether the recently announced proposed buyout of SEM shareholders is fair and provides investors with sufficient monetary consideration for their shares.Click here for additional information: https://kaskelalaw.com/case/select-medical/On March 2, 2026, Select Medical announced that it had agreed to...

BUYOUT INVESTIGATION ALERT: Kaskela Law Firm Announces Investigation into Fairness of Global Business Travel Group Inc. Shareholder Buyout and Encourages Investors to Contact the Firm – GBTG

PHILADELPHIA--(BUSINESS WIRE)--Investor protection firm Kaskela Law is investigating Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”) on behalf of the company’s shareholders to determine whether the recently announced buyout of GBTG shareholders is fair and provides investors with sufficient monetary consideration for their shares. Click here for additional information: https://kaskelalaw.com/case/global-business-travel-group/ On May 4, 2026, Amex GBT announced that it had agreed to...

TRADEWEB: Kaskela Law Firm Announces Investigation of Tradeweb Markets Inc. (TW) and Encourages Shareholders to Contact the Firm

PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law LLC announces that it is investigating Tradeweb Markets Inc. (NASDAQ: TW) (“Tradeweb”) on behalf of the company’s investors. The investigation seeks to determine whether Tradeweb and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties in connection with recent corporate actions. Tradeweb shareholders who would like to learn more about the investigation and their legal rights and options are encouraged...
Back to Newsroom